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Functional Magnetic Resonance 
Imaging of Electrical and 
Optogenetic Deep Brain 
Stimulation at the Rat Nucleus 
Accumbens
Daniel L. Albaugh1,2,3, Andrew Salzwedel2,4,5, Nathalie Van Den Berge1,2,6, Wei Gao2,4,5, 
Garret D. Stuber3,7 & Yen-Yu Ian Shih1,2,3,8
Deep brain stimulation of the nucleus accumbens (NAc-DBS) is an emerging therapy for diverse, 
refractory neuropsychiatric diseases. Although DBS therapy is broadly hypothesized to work through 
large-scale neural modulation, little is known regarding the neural circuits and networks affected by 
NAc-DBS. Using a healthy, sedated rat model of NAc-DBS, we employed both evoked- and functional 
connectivity (fc) MRI to examine the functional circuit and network changes achieved by electrical NAc 
stimulation. Optogenetic-fMRI experiments were also undertaken to evaluate the circuit modulation 
profile achieved by selective stimulation of NAc neurons. NAc-DBS directly modulated neural activity 
within prefrontal cortex and a large number of subcortical limbic areas (e.g., amygdala, lateral 
hypothalamus), and influenced functional connectivity among sensorimotor, executive, and limbic 
networks. The pattern and extent of circuit modulation measured by evoked-fMRI was relatively 
insensitive to DBS frequency. Optogenetic stimulation of NAc cell bodies induced a positive fMRI signal 
in the NAc, but no other detectable downstream responses, indicating that therapeutic NAc-DBS might 
exert its effect through antidromic stimulation. Our study provides a comprehensive mapping of circuit 
and network-level neuromodulation by NAc-DBS, which should facilitate our developing understanding 
of its therapeutic mechanisms of action.
Therapeutic deep brain stimulation (DBS) therapy has become an increasingly important clinical tool in neu-
ropsychiatry1,2. Among several targets under active clinical consideration for neuropsychiatric DBS, the nucleus 
accumbens (NAc, ventral striatum) is perhaps the most common. Functionally interfaced with both limbic and 
executive circuitry3, the NAc has emerged as a promising target for several neuropsychiatric conditions, including 
obsessive-compulsive disorder (OCD)4 and treatment-resistant depression5.
A longstanding issue with DBS therapy is the unpredictability of the cellular, circuit- and network-level 
responses to site-specific electrical stimulation, particularly at the high stimulation frequencies that are com-
monly employed (>100 Hz)6. Indeed, despite active clinical use, the therapeutic mechanisms of NAc-DBS are 
poorly understood, impeding the development and refinement of this promising therapy. Functional brain map-
ping tools, including positron emission tomography (PET) and functional magnetic resonance imaging (fMRI), 
are promising avenues for the study of circuit and network modulation by DBS therapy7,8. The key strengths 
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to fMRI-based studies of DBS include the ability to detect dynamic changes in stimulus-evoked activity and 
connectivity, in vivo, across the whole brain with reasonably high spatiotemporal resolution. Unfortunately, the 
implementation of fMRI tools to study NAc-DBS in clinical populations is strongly limited by both obstructive 
electrode imaging artifacts and appropriate safety considerations (largely pertaining to dangers associated with 
the introduction of DBS equipment to the MR environment)9.
In contrast to clinical populations, animal models of DBS can be readily studied with fMRI under far more 
flexible experimental conditions10–13. For example, long-duration scan sessions can be conducted to map the 
acute neural responses to DBS at varying stimulation frequencies. This is particularly important as DBS therapy 
for both movement and neuropsychiatric disorders is commonly employed only at high stimulation frequencies, 
suggesting frequency-dependent mechanism(s) of action6. In the case of NAc-DBS, the effects of stimulation 
frequency on neural circuit modulation have not been extensively explored using neuroimaging tools. DBS-fMRI 
in animal models also offers flexibility in electrode choice, in particular those built using more MR-compatible 
materials, reducing obstructive imaging artifacts14.
In the present study, we employed simultaneous DBS and multimodal fMRI to study the circuit and 
network-level effects of NAc stimulation in a healthy rat model. This model was chosen based on its widespread 
use in preclinical studies of NAc-DBS15–20. Electrical stimulation of the NAc strongly modulated prefrontal cor-
tex and a diverse complement of subcortical limbic regions, including many areas not previously detected by 
DBS-fMRI. We also provide the first global functional connectivity mapping of NAc-DBS at therapeutic stim-
ulation parameters. Broadly, these DBS-fMRI measurements provide critical information regarding both the 
pathways modulated by NAc-DBS, as well as the strength of modulation by DBS at therapeutic parameters. 
Interestingly, the detected pattern and size of CBV modulation by NAc DBS was largely insensitive to stimulation 
frequency. Supplementing our electrical DBS findings, we describe exploratory optogenetic-fMRI experiments 
with selective stimulation of NAc neurons.
Materials and Methods
Subjects. A total of 15 male Sprague-Dawley rats (300–500 g, Charles River Laboratories, Wilmington MA) 
were included in this study. Rats were individually housed in cages with food and water available ad libitum and 
12:12 day–night cycles with control of humidity and temperature. All procedures were performed in accordance 
with the National Institutes of Health Guidelines for Animal Research (Guide for the Care and Use of Laboratory 
Animals) and approved by the University of North Carolina Institutional Animal Care and Use Committee.
Experimental Overview. This study broadly consisted of four different experiments: 1) Evoked-fMRI of electri-
cal NAc-DBS at 130 Hz (300 μA stimulation); 2) Evoked-fMRI of electrical NAc-DBS to examine frequency-dependency 
of fMRI responses (10, 40, 70, 130, 200 Hz; 500 μA stimulation); 3) Functional connectivity (fc) MRI measurements of 
network-level responses to NAc-DBS at 130 Hz (300 μA stimulation); and 4) Evoked-fMRI responses to selective opto-
genetic stimulation of NAc neurons. Evoked- and fcMRI experiments were conducted in the same group of subjects 
(and scanning session), whereas optogenetic experiments were conducted in a separate group of subjects.
Stereotactic Surgery. For all surgical procedures, rats were endotracheally intubated and mechanically ven-
tilated using a small animal ventilator (CWE Inc., SAR-830/PA, Ardmore, PA). Anesthesia was maintained under a 
constant flow of 2% isoflurane mixed with medical air, and physiological parameters were continuously monitored 
and maintained within normal ranges using capnometry (Surgivet, Smith Medical, Waukesha, WI) and pulse oxi-
metry (MouseOx Plus, STARR Life Science Corp., Oakmont, PA). Animals were head-fixed to a stereotactic frame 
(Kopf Instruments, Model 962, Tujunga, CA), and burr holes were prepared according to experimental coordinates. 
For electrical DBS experiments, homemade MRI-compatible two-channel tungsten microelectrodes were fabricated 
as previously described14, and targeted to the mediodorsal boundary of the NAc core/shell (2.28 mm anterior to 
bregma, 1.2 mm right of midline, and 6.6 mm ventral to cortical surface). Two electrode leads (50 μm each in diam-
eter, approximately 1 cm in length), were adhered with a saturated sucrose solution for minimal interspace distance. 
These electrodes were fully insulated with polyimide except at the tips, with an in vitro impedance of 18–22 kΩ at 
1 kHz14. For optogenetic DBS experiments, viral microinjections were targeted to the same stereotactic coordinates 
used for electrode implantations. Injections were administered as either 1 or 2 μl volumes at a flow rate of 0.1 and 
0.2 μl/min, respectively (total infusion time = 10 min). An additional 10 min was given for virus diffusion prior to 
slow retraction of the microsyringe needle. Chronically-implantable optical fibers (200 μM; NA: 0.37)21 were placed 
0.5 mm above virus injection sites.
For all experiments, MR-compatible miniature brass screws (Item #94070A031, McMaster Carr, Atlanta, GA) 
were anchored to the skull, and dental cement was used to seal implanted components. Surgical sutures were 
employed to further protect the surgical site. For electrical DBS experiments, a recovery period of at least 24 h 
was given prior to fMRI, while at least three weeks were given for optogenetics experiments to allow for sufficient 
viral expression.
Functional MRI Scan Preparation. In preparation for fMRI procedures, rats were endotracheally intubated 
and mechanically ventilated using a small animal MR-compatible ventilator (CWE Inc., MRI-1, Ardmore, PA). 
Anesthesia was initially maintained under constant isoflurane (1.5–2%) mixed with medical air. Next, tail vein 
catheterization was performed for intravenous drug and contrast agent injections (see below). Immediately fol-
lowing intubation and tail vein catheterization, animals were placed within a head-holder, and harnessed to a small 
animal cradle (both plastic and custom-made). The cradle was lined with a circulating water blanket connected 
to a temperature-adjustable water bath located outside the scanner room (Thermo Scientific, Waltham, MA). 
A rectal probe was employed and core body temperature was maintained at 37 ± 0.5 °C. Mechanical ventilation 
volume and rate were adjusted to maintain EtCO2 of 2.8–3.2% and SpO2 above 96%, using capnometry (Surgivet, 
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Smith Medical, Waukesha, WI) and pulse oximetry (MouseOx Plus, STARR Life Science Corp., Oakmont, PA). 
EtCO2 values from the capnometry system were previously calibrated against invasive sampling of arterial blood 
gas, reflecting a pCO2 level of 30–40 mm Hg22,23.
Functional MRI. MR images were acquired on a 9.4-Tesla Bruker BioSpec system with a BGA-9S gradient 
insert (Bruker Corp., Billerica, MA). A homemade single-loop surface coil with an internal diameter of 1.6 cm, 
placed directly over the head, was used as a transceiver. Toothpaste was applied within the open coil loop to min-
imize MR susceptibility artifacts. The set-up of the coil and DBS electrode is shown in Fig. 1A.
Magnetic field homogeneity was optimized first by global shim and followed by local first- and second-order 
shims using the FASTMAP protocol24. For anatomical referencing, a T2-weighted RARE pilot image was 
taken in the mid-sagittal plane to localize the anterior commissure; this structure is located at approximately 
0.36 mm posterior to the bregma and served as a reference for anteroposterior slice positioning in subsequent 
anatomical and functional scans. T2-weighted anatomical images were obtained using a RARE sequence (scan 
parameters: TR = 2500 ms, TEeff = 33 ms, RARE factor = 8, slice thickness = 1 mm, matrix size = 256 × 256, 
FOV = 2.56 × 2.56 cm2). Twelve coronal slices were acquired, with the 5th slice from the anterior direction 
aligned with the anterior commissure (as revealed in the previous T2-weighted pilot scan). The reduced electrode 
distortion artifact (Supplemental Figure S1), together with standardized slice positioning, rendered these images 
sufficient to localize the electrode tip placement, as previously described12,14. As visualized slices were 1 mm thick, 
all correctly targeted electrodes fell within this coronal section we deemed this resolution adequate given the rel-
atively large anteroposterior size of the NAc. For optogenetic-fMRI experiments, optical fiber placements above 
the NAc virus injection site were similarly visualized using the anatomical images. Electrode and optical fiber 
placements within the NAc were confirmed for each rat (Fig. 1B and Supplemental Figure S1); animals with place-
ments outside of the target regions or defective electrodes were discarded for subsequent experiments (n = 3).
Following setup processes and immediately prior to cerebral blood volume (CBV) fMRI scan acquisition, rats 
were administered Feraheme (30 mg Fe/kg, i.v.). Subsequently, anesthesia was switched from 1.5–2% isoflurane 
to sedation using dexmedetomidine (dexdomitor; 0.05 mg/kg/hr, i.v.) cocktailed with the paralytic agent pancu-
ronium bromide (0.5 mg/kg/hr, i.v.) (to facilitate mechanical ventilation). This cocktail was administered for the 
remaining scan duration, continuously supplemented by 0.5% isoflurane25. A delay of at least 10 min was given 
before beginning fMRI experiments, to allow animals to adjust to sedation. Total experimental duration was lim-
ited to a maximum of three hours (following dexmedetomidine administration for all subjects.
CBV fMRI was chosen against the more traditional blood-oxygen-level-dependent (BOLD) fMRI due to its 
superior contrast-to-noise ratio26. CBV fMRI scans were acquired using a multi-slice single-shot gradient echo 
echo-planar imaging sequence (GE-EPI) (scan parameters: TR = 1000 ms, TE = 8.1 ms, bandwidth = 250 kHz, 
slice thickness = 1 mm, matrix size = 80 × 80 (zero-padding to 128 × 128), and FOV = 2.56 × 2.56 cm2. Image 
slice geometry was imported from the previously acquired T2-weighted anatomical image (12 slices).
Deep Brain Stimulation (DBS). Simultaneous electrical DBS with CBV fMRI was acquired in the same 
manner for all subjects showing accurate electrode placement (n = 9), using bipolar and uniformly-distributed 
unilateral stimulation of the right NAc. Subjects with inaccurate electrode placement were excluded for subse-
quent experiments. Each stimulation period consisted of a series of TTL-triggered biphasic, charge-balanced 
square-wave pulses delivered at 130 Hz, with a stimulation intensity of 300 μA and pulse duration of 90 μs 
(Experiment 1). A 70 s block design paradigm was implemented (adopted from one of our previous DBS-fMRI 
studies)12, consisting of 20 s of rest (stimulation OFF) followed by 10 s of stimulation ON, and an additional 
40 s of rest (stimulation OFF). In a second set of experiments designed to test frequency-dependency of 
DBS-evoked CBV modulation (Experiment 2), higher current amplitude was employed (500 μA). These exper-
iments, conducted prior to the observation of detectable CBV responses at 300 μA, nevertheless fall within nor-
mal amplitude ranges (or lower) for rodent DBS-fMRI experiments12,27. Stimulation frequencies were varied 
Figure 1. (A) Schematic of experimental imaging setup with a custom single loop surface coil and a 
tungsten microwire electrode. (B) Electrode tip mapping to the NAc for all electrical DBS subjects (n = 9). 
Tip placements were estimated using T2-weighted anatomical scans, which we deemed satisfactory given the 
relatively large size of the NAc (including anteroposterior distance), as well as the reduced electrode artifact.
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in a pseudo-randomized order (i.e., 130, 40, 70, 200, 10 Hz), consistent across subjects yet designed to elimi-
nate potential stimulation frequency order effects. The application of a fixed pulse duration in this experiment 
(i.e., 90 μs), while varying total charge delivered by stimulation frequency, was chosen to mimic the short pulse 
durations used clinically, which may be biased for targeting axons over somata28. Each DBS frequency scan was 
repeated 5-times per rat for within-subject/session averaging (note that all descriptions of n refer to total rat 
number). An additional rest period of at least two min was given between all evoked-fMRI DBS scans (electrical 
and optogenetic [see below]) to allow for neurovascular recovery.
For Experiment 3, fcMRI scans were acquired using EPI scan parameters identical to those for evoked-fMRI 
data (see above), however with a 5 min (300 frame) scan duration (n = 7). First, a pre-stimulation (“resting”) 
baseline scan was acquired, wherein no NAc-DBS was applied. Immediately afterwards, a second fcMRI scan 
was acquired with simultaneous, continuous 130 Hz NAc-DBS (300 μA). This was again followed by a resting, 
post-stimulation scan in which no DBS was applied.
In Experiment 4, a pilot experiment examining the evoked-fMRI responses to optogenetic stimulation at NAc 
(n = 4 for ChR2; n = 2 for EYFP control), a 473 nm wavelength diode-pumped solid-state (DPSS) laser (model 
BL473T8-200, Shanghai Laser & Optics Century, Shanghai, China) was connected via coupler to a homemade 
patch cable terminating above the chronically-implanted optical fibers. Wavelength-specific light output at the 
terminating end of the patch cable was pre-calibrated to 20 mW using a wattage meter. Optogenetic stimulation 
periods consisted of a series of TTL-triggered light pulses with a stimulation frequency of 40 Hz and pulse dura-
tion of 5 or 10 ms. A 100 s block design paradigm was implemented, consisting of 20 s rest (stimulation OFF) 
followed by two 10 s stimulation periods (stimulation ON), with intervening and final rest periods of 30 s.
Stimulus-Evoked Data Processing and Statistical Analyses. Preprocessing and image analysis was 
performed using SPM codes and a custom-written program in Matlab (MathWorks Inc., Natick, MA) similar 
to our previous DBS-fMRI studies10,12,14. CBV fMRI data were automatically realigned to the first volume of a 
well-positioned subject. These datasets were semi-automatically skull-stripped using a thresholding method and 
coregistered to an anatomical MRI rat atlas29.
Functional DBS response maps were generated using the general linear model (GLM), statistical significance 
was set at p ≤ 0.05. To control for multiple comparisons, the Benjamini and Hochberg/Yekutieli procedure for 
controlling false discovery rate was utilized30. All images were smoothed by applying a mean filter with a 3 × 3 
kernel, and overlaid on an anatomical MRI rat atlas29. Responses are expressed in T-score units ranging from 2 
to 10.
For temporal analysis of electrical DBS-evoked CBV changes, 3-dimensional regions of interest (ROIs) were 
defined a priori according to anatomical structural boundaries29,31, and applied onto the coregistered data. The 
ROIs chosen for time-course analysis included only those regions showing statistically significant modulation 
during 130 Hz DBS with 300 μA current (see Fig. 2).
The effect of DBS stimulation frequency on ΔCBV change was calculated by averaging CBV values from 
the 10 second stimulation epochs. The baseline ΔR2* value was calculated as follows: Baseline ΔR2* = −1/TE 
ln(Sprestim/S0), where Sprestim and S0 represents MR signal intensity after and before Feraheme injection. Stimulus 
evoked ΔR2* values were calculated as follows: Stimulus evoked ΔR2* = −1/TE ln(Sstim/Sprestim), where Sstim and 
Sprestim are the MR signal intensities during and before stimulation, respectively. Cerebral blood volume changes 
were calculated by dividing stimulus-evoked ΔR2* by baseline ΔR2* values; because Sprestim is used to calculate 
baseline ΔR2* for each stimulation session, this corrects for any potential baseline drift. Statistical comparisons of 
DBS frequency effects on ΔCBV for each ROI were conducted using Graphpad Prism software (San Diego, CA). 
Two-tailed, one-way repeated measures ANOVA tests were conducted with Tukey post-hoc analyses. Statistical 
significance was set at p ≤ 0.05.
Functional Connectivity Data Processing and Statistical Analyses. Functional scans were preproc-
essed using the Analysis of Functional NeuroImages software suite (AFNI v2011-12-21-1014). The workflow 
included discarding the first 20 volumes, slice-timing correction, motion correction, alignment to a pre-existing 
high-resolution T2-weighted template, spatial smoothing (Gaussian kernel FWHM = 1.5 mm), low-pass filtering 
(0.001 Hz), and regression of whole brain signal and the six motion parameters. The number of volumes discarded 
was increased from the traditional number (approximately 3–10) in order to ensure DBS-related changes from the 
initial stimulation were minimized. Furthermore, warping in the alignment procedure was limited to shifts and 
rotations to avoid unnecessary shearing and scaling of brain regions with signal drop-out associated with the DBS 
electrode. fcMRI analyses were conducted using the temporal correlation method. Fisher-Z transformed correla-
tion matrices were generated using the average functional time series extracted for each region-of-interest (ROI) 
in the template atlas. Left (LH) and right hemispheres (RH; ipsilateral to DBS electrode) ROIs were analyzed 
separately yielding correlation matrices detailing within and between hemisphere connectivity. The ROIs were 
further separated into two putative networks, a NAc-DBS network consisting of regions with robust DBS-evoked 
responses, as well as the ventral tegmental area (due to its highly established involvement in NAc circuitry)3 ver-
sus Other, a network made up of 30 miscellaneous brain regions. The NAc-DBS network included the following 
15 regions: prelimbic cortex (PLC), infralimbic cortex (ILC), orbitofrontal cortex (OFC), cingulate cortex (CC), 
insula, nucleus accumbens (NAc), anterior striatum (AS), ventral pallidum (vPall), septum (Sept), lateral hypo-
thalamus (lHyp), amygdala (Amyg), bed nucleus of the stria terminalis (BNST), mediodorsal thalamus (MDT), 
ventral hippocampus (vHipp), and the ventral tegmental area (VTA). Repeated measures analyses of variance 
(MATLAB, rANOVA) were implemented in order to test the effects of the stimulation paradigm (Pre-DBS Rest, 
DBS, Post-DBS Rest) and the interaction with mean connectivity responses within and between hemispheres 
(RH, LH, RH ↔ LH) across animals (n = 7). P-values were assessed using the more conservative lower-bound 
estimate (plb) in order to correct for potential violations in symmetry.
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Individual connections, or pair-wise correlations (i.e. NAc ↔ OFC, etc), were further evaluated in the context of the 
stimulation paradigm and relative direction of effect (Connectivity versus Condition). Direction of effect was deter-
mined by fitting each significant (rANOVA, p ≤ 0.05 uncorrected) set of pair-wise connections with a 2nd -order pol-
ynomial. The resulting sign of the quadratic term was used to categorize connections as either enhanced (increased 
correlation) or suppressed (increased anti-correlation). Pair-wise connections with weak modulation (|ΔZ-corr.| < 0.10) 
were ignored. Finally, connections were grouped based on network classifications (sensorimotor, executive, limbic, and 
between network connections) and then visualized on coronal and volumetric representations of the rat template brain.
Optogenetic Constructs. For optogenetic experiments, neuronal opsin expression was achieved using 
adeno-associated viral vectors (AAV, serotype 5), encoding either a humanized variant of ChannelRhodopsin-2 
(hChR2; H134R) fused to an enhanced yellow fluorescent protein (EYFP), or EYFP alone. Both constructs were 
placed under the calcium-calmodulin kinase IIα (CaMKIIα) promoter to target striatal neurons. Viral titers were 
approximately 5.0 × 1012 viral genome/ml. All viruses were obtained from the Vector Core at the University of 
North Carolina at Chapel Hill.
Histology. Following scan procedures, rats were deeply anesthetized with a 1–2 ml cocktail of pentobarbital 
sodium and phenytoin sodium (Euthasol) and transcardially perfused with saline followed by 10% formalin. 
Extracted brains were stored overnight in 10% formalin and transferred to a 30% sucrose solution (in DI water) 
for 2–3 days, until brains sunk to bottom of storage bottles. Brains were cut to 40 μm thick sections on a freezing 
microtome and mounted on glass slides for fluorescent imaging. Vectashield mounting medium with DAPI stain 
(Vector laboratories, Item # H-1200) was used to provide a cell body counterstain. Slides were imaged using a 
Zeiss 780 confocal microscope.
Results
Electrode targeting accuracy within the NAc was verified using T2-weighted anatomical scans (Fig. 1B). Given 
the possibility of current spread to the shell region during DBS, we did not differentiate between these anatomical 
subdivisions in this study.
To evaluate the downstream neural circuitry modulated by NAc-DBS at 130 Hz (300 μA), CBV functional 
activation maps were generated using an evoked-fMRI acute stimulation paradigm (Fig. 2). These maps revealed 
positive CBV responses to NAc-DBS in many brain regions with known executive and/or limbic functions; these 
included: amygdala, infralimbic cortex, lateral hypothalamus, NAc, prelimbic cortex, septum, ventral hippocam-
pus, and ventral pallidum. Positive CBV changes observed along the electrode tract were time-locked to the 
Figure 2. Functional CBV activation maps by 130 Hz NAc-DBS (300 μA; n = 5). CBV modulation was 
largely ipsilateral to the stimulated hemisphere, was predominantly positive in direction, and included 
both cortical and subcortical CBV modulation. Notable regions demonstrating CBV increases included the 
prefrontal cortex (including prelimbic, infralimbic, and orbitofrontal), NAc, lateral hypothalamus, amygdala, 
ventral hippocampus and others. CBV decreases were also detected within a small region of the ipsilateral 
dorsal striatum. 12 slices were acquired in each scan, with numbers below slices denoting relative distance 
from bregma (in mm). Color bar denotes t score values obtained by GLM analyses, with a significance 
threshold of p < 0.05 (corrected). Functional activation maps for all additional tested frequencies are located in 
Supplemental Figures S4.
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stimulation period, and not present in DBS-fMRI studies conducted with the same electrode at different targets 
(e.g., thalamus)14, strongly suggesting a neural origin. Minor CBV decreases were also detected in a small subre-
gion of the dorsolateral striatum. Interestingly, although each of these regions has known anatomical connectivity 
with the NAc (in many cases as nonreciprocal glutamatergic inputs to the NAc)32, anatomical connectivity alone 
was insufficient to predict responsive brain regions. For example, the ventral tegmental area, which is densely and 
reciprocally connected to the NAc33,34, did not show detectable CBV modulation by 130 Hz NAc-DBS (see Fig. 2 
and Supplemental Figure S3).
Next, we undertook fcMRI experiments to study the effects of NAc-DBS over longer time periods (minutes). 
Previous electrophysiological and neuroimaging studies have provided evidence of network synchrony modula-
tion by high frequency NAc-DBS15,35. Exploiting the capability of fcMRI to measure functional connectivity on a 
whole-brain scale, we mapped global network changes induced by NAc-DBS at 130 Hz (300 μA). Mean correlation 
matrices were generated for each stimulus condition (Pre-DBS, DBS, Post-DBS) across 90 anatomically-defined 
ROIs (45 ROI’s per brain hemisphere) (Fig. 3A). These ROIs were grouped into two pre-defined networks, based 
on our evoked fMRI findings (see Methods; NAc-DBS [#s 1–15] and Other [#’s 16–45]). A complete listing of 
ROIs and network groupings is provided in the Fig. 3 key and associated figure caption. For the Pre-DBS con-
dition, bilateral connectivity was evident between homologous ROIs, and for certain structures appeared more 
robust (i.e. PLC, ILC, OFC, CC, Insula, Motor, etc). The presence of bilateral functional connectivity, as displayed 
in our datasets, represents a key feature of fcMRI36. Except for a small number of ROIs (i.e. NAc ↔ OFC), within 
hemisphere connectivity was overall low in the Pre-DBS condition, possibly due to the short sampling period 
(5 mins per trial). However, during NAc-DBS of the RH NAc, within RH connectivity (i.e. ipsilateral to the DBS 
site) increased between many of the “NAc-DBS related network” ROIs, whereas there was little apparent modu-
lation in the “Other network”. Between NAc-DBS network connectivity also appeared slightly modulated in the 
DBS condition but for a smaller number of ROIs (i.e. PLC, ILC). Post-DBS connectivity for the DBS-NAc network 
was similar, or perhaps intermittent to the pre-DBS / DBS conditions.
Next, histograms were generated (Fig. 3B) and fit as t-distributions for each stimulus condition, network, and 
connectivity grouping (within and between hemispheres) using average measures from the connectivity matrices. 
Consistent with the previous observations, NAc-DBS network connectivity within the RH was the only distribu-
tion to show enhanced positive correlations during DBS stimulation of the RH NAc. Repeated measures analyses 
of variance (rANOVA) were used to statistically validate these results across animals. For the NAc-DBS network, 
the stimulus condition (Pre-DBS, DBS, Post-DBS) and interaction between condition and connectivity (RH, 
LH, RH ↔ LH) were significant (plb ≤ 0.05); Condition F(2,41) = 7.45, plb = 0.014 and Condition*Connectivity 
F(4,41) = 4.15, plb = 0.033.
Visualization of significantly (rANOVA, p < 0.05 uncorrected, ΔZ-Corr > 0.10) enhanced (increased cor-
relation) or suppressed (decreased correlation or increased anti-correlation) individual pair-wise connec-
tions grouped by functionally-defined networks (Sensorimotor, Executive, Limbic, and Between Network 
Connections) paralleled the above observations and revealed additional information that was not readily appar-
ent in the original classification of the data (Fig. 4; blue-suppressed, red-enhanced). Enhancement was primar-
ily restricted to connections between RH limbic structures, however consistent suppression was also evident, 
mainly within the sensorimotor network and between limbic and motor regions. The sensorimotor network 
showed no significant enhancement, and moreover, the executive network was devoid of suppressed connec-
tions. Enhancement was relatively robust (Fig. 4, ΔZ-Corr > 0.20 thick red lines) for the following connections; 
R-NAc ↔ R-Sept, R-PLC and R-ILC ↔ R-PLC. Additional analyses of fcMRI data are provided in Supplemental 
Figures S5 and 6.
To investigate the frequency-dependency of CBV responses to NAc-DBS, we next conducted additional 
evoked-fMRI experiments with five DBS frequencies (10, 40, 70, 130 and 200 Hz). To achieve a more robust meas-
urement of the frequency effects and circumvent the issue of low DBS-fMRI sensitivity at low stimulus ampli-
tude this experiment was conducted using a slightly higher current intensity at 500 μA37. The results generated 
CBV response patterns that were qualitatively similar, yet more robust responses than 300 μA (see Supplemental 
Figure S4). This current remains to be lower than in many previously reported DBS-fMRI studies12,14,37,38, and 
we thus do not expect significant off-target effects. To further reduce bias towards characterizing off-target areas 
with this stronger current amplitude, we only evaluated anatomical ROIs that were significantly modulated 
with 300 μA stimulation (at 130 Hz; Fig. 2). This ROI-based analysis included two complementary measures of 
regional activity modulation: CBV time-courses and amplitudes; both are quantitative measures of percent CBV 
changes. CBV time-courses generated from 10 Hz NAc-DBS resulted in weak or no change in CBV (though see 
Supplemental Figure S4 demonstrating sparse CBV increases in and surrounding the NAc), whereas all other 
frequencies resulted in region-specific CBV increases of similar amplitudes and rise/decay kinetics (Fig. 5A). The 
absence of distal CBV responses with 10 Hz NAc-DBS is remarkable, as DBS at this stimulation frequency has 
been shown to generate robust downstream fMRI signals at other target locations (e.g., the ventroposteromedial 
thalamus)14. In general, NAc-DBS induced sharp rises in CBV that returned to baseline values by the end of the 
test period (i.e., with 40 s of recovery). The largest CBV increases were detected in the NAc, infralimbic, and 
prelimbic cortices, each displaying maximal increases in CBV ~20% above baseline values. Among all regions 
showing significant and detectable responses, the ventral hippocampus displayed perhaps the weakest, with a 
maximal CBV increase of just over ~5% from baseline. Interestingly, the duration to peak CBV amplitude varied 
in a region-specific manner. For example, CBV continued to increase in the lateral hypothalamus and septum 
for the duration of the stimulation period, while CBV values peaked and decayed more rapidly in prefrontal 
cortex. Quantitative comparisons of CBV amplitude modulation by NAc-DBS at varying frequencies are shown 
in Fig. 5B. One-way ANOVAs revealed a significant main effect of NAc-DBS frequency on the amplitude of 
CBV change for all regions examined. Remarkably, post-hoc testing revealed that while 40–200 Hz NAc-DBS 
significantly increased CBV compared to the 10 Hz condition, no other significant frequency-dependent effects 
www.nature.com/scientificreports/
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Figure 3. fcMRI modulation by 130 Hz NAc-DBS. (A) Mean correlation matrices (n = 7) for each stimulus 
condition (Pre-DBS, DBS, Post-DBS) using 45 regions-of-interest (ROIs, see Figure Key). ROIs were chosen 
a priori, with reference to anatomical regions described in a standard rat brain atlas35. Note the presence of 
between-hemispheric regional connectivity (displayed as a red diagonal line) in all matrices. (B) Histograms 
and t-distribution fits for each stimulus condition, network (NAc-DBS [ROIs #s 1–15] and Other [ROIs #’s  
16–45]) and connectivity grouping (within and between hemispheres) using correlation measures from 
the average correlation matrices. Abbreviations: PLC: Prelimbic Cortex; ILC: Infralimbic Cortex; OFC: 
Orbitofrontal Cortex; CC: Cingulate Cortex; Insula: Insular Cortex; NAc: Nucleus Accumbens; AS; Anterior 
Striatum; vPAll: Ventral Pallidum; Sept: Septum; lHyp: Lateral Hypothalamus; Amyg: Amygdala; BNST: Bed 
Nucleus of the Stria Terminalis; MDT: Mediodorsal Thalamus; vHipp: Ventral Hippocampus; VTA: Ventral 
Tegmental Area; AC: Auditory Cortex; AOB: Accessory Olfactory Bulb; DLS: Dorsolateral Striatum; DMS: 
Dorsomedial Striatum; ENT: Entorhinal Cortex; GPe: External Globus Pallidus; Motor: Motor Cortex (Primary 
and Secondary); OT: Olfactory Tubercle; PAG: Periaqueductal Grey; PPTg: Pedunculopontine Tegmental 
Nucleus; PC: Parietal Cortex; Piriform: Piriform Cortex; pHyp: Posterior Hypothalamus; pThal: Posterior 
Thalamus; S2: Secondary Somatosensory Cortex; SN: Substantia Nigra; Somato: Primary Somatosensory 
Cortex; STN: Subthalamic Nucleus; TeA: Temporal Association Cortex; VL: Ventrolateral Thalamus; VPL: 
Ventral Posterolateral Thalamus; Visual: Visual Cortex (Primary and Secondary); ZI: Zona Incerta; dHipp: 
Dorsal Hippocampus; dRaphe: Dorsal Raphe Nucleus; lHab: Lateral Habenula; mPOA: Medial Preoptic Area; 
SC: Superior Colliculus; vHyp: Ventral Hypothalamus.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:31613 | DOI: 10.1038/srep31613
of NAc-DBS on CBV amplitude were noted. That is, increasing the frequency of NAc-DBS from 40 to 200 Hz, a 
five-fold difference, did not further modulate the functional circuit responses in the structures that we investi-
gated. Critically, evoked responses were generally consistent across multiple stimulation trials, arguing against the 
possibility of stimulation-induced neural damage.
In addition to electrical stimulation, optogenetic tools are being increasingly exploited for mapping func-
tional connectivity among neural circuits. Several studies have also employed optogenetic stimulation to 
elucidate potential mechanisms of therapeutic DBS action, including at the nucleus accumbens target39. In 
experiments reported here, we explored the possibility of using optogenetic NAc stimulation to induce detect-
able downstream fMRI signals. This pilot experiment was performed in rats that received viral injections of an 
adeno-associated virus encoding ChR2 under the neuron-specific CaMKIIα promoter. A representative example 
of virally-mediated ChR2 expression in NAc neurons is provided in Fig. 6A. Optogenetic stimulation at 40 Hz 
evoked a local positive CBV signal in the NAc, with no significant CBV modulation observed outside the tar-
get region (Fig. 6B,C). Ongoing studies in our laboratory using a completely identical experimental setup and 
analysis pipeline have revealed robust optogenetic-induced responses in downstream areas far from the stimu-
lation site. Thus, we are confident that our findings do not reflect a technical failure to manipulate NAc neurons 
optogenetically.
A recent study has demonstrated hemodynamic changes following blue light laser stimulation (50% duty 
cycle) in naïve rat brain, possibly due to a laser heating artifact40. To evaluate the possibility of such an artifact as 
the source of the observed optogenetic response at the NAc, we repeated our optogenetic-fMRI experiments in 
control rats expressing an inert EYFP fluorophore in the NAc. In these animals, no significant CBV modulation 
by NAc-DBS was observed (Fig. 6B,C). It is worth noting that our laser pulse duration was substantially shorter 
than that previously reported to induce laser artifacts, likely explaining the absence of such a response caused by 
laser heating. Local heating artifacts in optogenetic-fMRI experiments have since been examined in greater detail, 
including suggested control experiments to rule out such artifacts as causal in fMRI signal generation41.
Discussion
In this study, we performed multimodal fMRI procedures to identify neural circuitry modulated by NAc-DBS in 
a healthy rat model. Evoked fMRI with electrical DBS uncovered a broad range of cortical and subcortical regions 
displaying stimulation-induced CBV increases, including prefrontal cortex, lateral hypothalamus, amygdala, 
septum, and ventral hippocampus. fcMRI provided corroborative evidence of robust network modulation by 
NAc-DBS, including suppression of sensorimotor and enhancement of executive and limbic network connectiv-
ity. Lastly, we performed opto-fMRI with selective and direct stimulation of NAc neurons, showing time-locked 
CBV increases exclusively localized in the NAc during 40 Hz optical stimulation.
Although high frequency DBS is generally reported to locally silence neuronal activity42,43, we noted only 
CBV increases in the target region (i.e., the NAc) across all tested stimulation frequencies. This finding is con-
sistent with a number of human neuroimaging studies reporting increases in hemodynamic responses or glucose 
metabolism in the subthalamic nucleus (STN) during STN-DBS7. Notably, each of these studies (including our 
own) uses indirect measures of neuronal activity, and thus this seeming paradox may possibly be explained by 
an uncoupling of hemodynamic responses from neuronal spiking during high frequency stimulation. DBS may 
induce both depolarization blockade and augmented presynaptic activity, either of which may potentially increase 
Figure 4. Network-level visualization of pair-wise fcMRI modulations during 130 Hz NAc-DBS. Significant 
(rANOVA, p ≤ 0.05 uncorrected, ΔZ-Corr > 0.10) enhanced (red) or suppressed (blue) individual pair-wise 
connections grouped by functionally-defined networks (Sensorimotor, Executive, Limbic, and Between 
Network Connections). Thick red lines represent ΔZ-Corr > 0.20 at R-NAc ↔ R-Sept, R-PLC and R-ILC ↔ R-PLC.
www.nature.com/scientificreports/
9Scientific RepoRts | 6:31613 | DOI: 10.1038/srep31613
local metabolic demand in the absence of somatic spiking44. In this context, it is also interesting to note several 
reports of local increases in c-fos expression following DBS of the NAc, STN, or pedunculopontine tegmental 
nucleus in rats45–47. Future studies may determine the nature and extent of this possible uncoupling, which has 
strong implications for the interpretations of neuronal activity based on indirect experimental measures such as 
fMRI or immediate early gene expression.
Complementing our evoked-fMRI findings of direct limbic circuit modulation by NAc-DBS, fcMRI meas-
urements revealed robust enhancements in functional connectivity between many of these same regions. More 
generally, limbic and executive network connections were primarily enhanced but those in the sensorimotor 
network were largely suppressed. These findings suggest that NAc-DBS modulates multiple functional network 
domains, spanning the entire brain. Although these functional connectivity maps alone do not allow for causal 
inferences relating to the therapeutic mechanism of NAc-DBS, they should provide an invaluable resource for the 
generation of future, hypothesis-driven DBS studies.
A central tenet of DBS therapy is its dependence upon high stimulation frequencies. One widely held hypothesis 
of DBS action posits that high frequency stimulation masks pathological endogenous circuit activity, thus creat-
ing an “informational lesion” at the DBS target (although other mechanisms have also been posited)48–50. We were 
thus surprised to find that the functional activation profile obtained by NAc-DBS in rats was remarkably insensi-
tive to a wide range of stimulation frequencies; indeed, 40 Hz stimulation modulated CBV across all tested areas 
in a manner quantitatively similar to all higher frequencies tested, including 200 Hz. Although we used a healthy 
rodent model, precluding behavioral tests of DBS efficacy, our evoked-fMRI results highlight strong parallels in 
circuit modulation by either moderate or high frequency stimulation of the NAc. Further, a recent preclinical 
study of NAc-DBS for cocaine addiction reported similar attenuation of reinstated drug-seeking behavior at 20 or 
160 Hz, suggesting that some behavioral effects of NAc-DBS may also be frequency-insensitive17. The frequency 
sensitivity of symptom amelioration by NAc-DBS would be interesting to study in the clinical setting, particularly 
in light of the possibility of prolonging the battery life of DBS pulse generators using lower frequency stimulation 
protocols.
In this study, we have also provided preliminary data concerning the fMRI signal pattern generated by opto-
genetic stimulation of the NAc in a small number of subjects. We were surprised to discover that, in our setup, 
optogenetic NAc stimulation evoked detectable CBV increases solely within the NAc, whereas identical param-
eters used at other target regions revealed significant downstream responses. The lack of distal responses in the 
present experiment is particularly perplexing in that neural activity within the target region itself was clearly 
and robustly modulated by optogenetic stimulation. The reason for such large differences in circuit modulation 
Figure 5. Temporal dynamics (A) and amplitudes (B) of CBV responses to NAc-DBS across five stimulation 
frequencies (10, 40, 70, 130, 200 Hz; n = 8 per frequency), demonstrating that CBV responses to NAc-DBS were 
largely stimulation frequency-insensitive. All subjects were scanned with 500 μA DBS, except one subject with 
600 μA. CBV responses are expressed as a percent change from pre-stimulation baseline values. Amplitudes 
were calculated as mean percent CBV changes during stimulation epochs (10 seconds; scan frames 21–30). 
Anatomically-defined ROIs are highlighted as figure inserts in 5A (Single slice shown; note that many ROIs 
encompassed multiple slices). *p ≤ 0.05 for 10 Hz compared to all other frequencies (no other statistically 
significant comparisons). Datapoints are presented as mean ± SEM.
www.nature.com/scientificreports/
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patterns between optogenetic and electrical NAc stimulation is unclear, although several possibilities exist. 
First, stimulus intensity differed between optogenetic and electrical DBS in this study, which may contribute to 
the differing activation patterns. Second, although we have assumed that both electrical and optogenetic stim-
ulation delivered at 40 Hz would activate (rather than suppress) neural circuits, this was not formally tested. 
Another possibility concerns more fundamental differences between these stimulation approaches, such as the 
confinement of optogenetic stimulation to the opsin-expressing neurons and their efferent fibers. However, we 
also cannot entirely rule out the possibility that ChR2 was expressed in a small population of non-neuronal 
cells. The most likely explanation for our findings, in our opinion, is that most of the circuits recruited by 
NAc-DBS were resulted from antidromic activation of axons or fibers of passage. Our future studies will focus 
on evaluating this hypothesis.
There are several limitations to the present study to consider. First, although the NAc is generally considered to 
be comprised of two related, yet distinct subdivisions (core and shell) each with distinct circuit features3,32. We did 
not distinguish between these two areas in our experiments. Indeed based on the obtained functional response 
profiles, both regions were likely recruited by our stimulation paradigm. The core and shell subregions are both 
candidate therapeutic targets for neuropsychiatric DBS, but the efficacy of each may strongly depend upon the 
Figure 6. Optogenetic stimulation at NAc evokes local CBV increases. (A) Schematic of optogenetic 
stimulation at NAc (top), representative confocal image confirming ChR2 expression (green) in the NAc 
(bottom). Counterstain is DAPI (blue). ChR2 expression appeared strongest in the core subregion of the NAc. 
(B) Functional CBV responses induced by 40 Hz optogenetic stimulation at NAc in animals expressing ChR2 
or EYFP (AAV5 using the CaMKIIα promoter; n = 4 and 2, respectively). Note that optogenetic stimulation 
of the NAc resulted in CBV increases locally within the stimulated region, with no detected downstream 
responses. No responses were observed in EYFP subjects. Anteroposterior slice coordinates are as described for 
Fig. 2. Temporal CBV dynamics (C) and amplitudes (D) within the NAc during local optogenetic stimulation. 
Stimulation-evoked CBV amplitude changes were calculated as described in Methods.
www.nature.com/scientificreports/
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disorder being treated. For example, NAc-DBS for OCD generally targets the core region51,52, while some preclin-
ical studies suggest that the shell is more effective for addictive disorders19,46,53. Other behavioral phenotypes, such 
as quinpirole-induced checking behavior (a pharmacological model of OCD symptoms), are similarly influenced 
by NAc-DBS of the core or shell54. Further studies are necessary to elucidate the downstream circuitry that con-
fers unique therapeutic properties of DBS at either NAc subdivision.
A second major limitation of our study was the usage of dexmedetomidine sedation27,36, which may alter 
the responsivity of neural circuits to the effects of DBS. Related to this point, we were unable to reliably achieve 
robust fMRI responses with current amplitudes below 300 μA (data not shown), and thus our experiments relied 
upon higher amplitudes than those generally used in preclinical DBS studies in awake rodents (typically 100–
150 μA)15,16,19, although amplitudes higher than 150 μA have been reported for studies in both awake and anes-
thetized states18,55. We postulate that the relatively higher current amplitudes needed for DBS effects in our model 
may have been necessitated by the sedation state, the detection sensitivity of our fMRI measurements, or both.
A third limitation concerns the use of an acute stimulation paradigm, which was necessary in the context of 
our experimental MR setup. Similar OFF-ON-OFF paradigms are traditionally used in DBS-fMRI studies11–13,56, 
although they may provide a biased perspective on DBS-evoked changes in functional connectivity. A recent 
report by Ewing and Grace highlights the importance of studying DBS network effects under chronic stimulation 
conditions15. In that study, local field potentials (LFPs) were recorded in multiple brain regions of rats receiving 
continuous NAc-DBS for a period of 5 days. Some of the observed DBS-induced network changes were transient, 
including enhanced delta power in the mediodorsal thalamus and orbitofrontal cortex, whereas other network 
effects emerged over time (e.g., decreased alpha power in the mediodorsal thalamus). This work highlights the 
importance of studying DBS effects over more translationally-relevant timespans (days or weeks, if experimen-
tally feasible). fcMRI, which does not require within-session baseline (“OFF”) periods, provides an ideal experi-
mental measure for future longitudinal examinations of DBS effects across time and brain regions.
In the present study, we identified a robustly recruited network of cortical and subcortical circuits modulated 
by NAc-DBS, many of which are likely to be antidromically-stimulated. Remarkably, the extent of this circuit 
modulation was relatively frequency-insensitive, as demonstrated by our evoked-fMRI findings. Collectively, 
our findings should facilitate the understanding of DBS mechanisms and mapping of therapeutic circuits at this 
important clinical target. Future NAc-DBS fMRI studies should examine the circuit- and network-level responses 
to therapeutic stimulation in neuropsychiatric disease models, wherein pathology-specific circuit disruptions 
(and putative amelioration by DBS) may be explored.
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